Literature DB >> 31540807

The Etiology of Peyronie's Disease: Pathogenesis and Genetic Contributions.

Kiran L Sharma1, Manaf Alom1, Landon Trost2.   

Abstract

INTRODUCTION: Peyronie's disease (PD) is a chronic fibrosing condition that contributes to penile deformity, curvature, and pain. Initial familial studies demonstrated potential genetic links to PD. Since that time, very few investigations have significantly advanced the science in this area. Hence, there is a large opportunity and significant need to better study the underlying genomics and pathogenesis of PD. AIM: To summarize the current genomic literature relevant to PD.
METHODS: A review was performed of all PubMed-indexed literature from 1970-2018 relating to the pathophysiology and genetics of PD. Key findings were categorically summarized to include epidemiology, risk factors, inheritance patterns, chromosomal instability, genetic associations, epigenetics, differential gene expression, and preclinical models of PD. MAIN OUTCOME MEASURES: Summary of the current literature on the genetics of PD.
RESULTS: PD is a common condition and has several known risk factors and comorbid disease associations. Although men with PD are believed to be genetically predisposed, there are likely several subtypes of the condition, each with varied pathophysiological disorders and contributing factors. Available data suggest that PD is associated with underlying genetic instability, including dysregulation of genes relating to fibrosis and cellular degradation, thus, resulting in abnormal plaque development and penile deformity. Preclinical models, including cell cultures and rat models, demonstrate several consistencies with PD clinical and histopathologic characteristics; however, an ideal model with spontaneous development of PD is lacking.
CONCLUSION: Based on limited data, PD likely represents a heterogeneous condition, with both heritable and environmentally-driven epigenetic factors contributing to its development and progression. However, there remains a significant gap in the literature on the underlying cause and pathophysiology of the condition, suggesting a substantial need for further investigation and study. Sharma KL, Alom M, Trost L. The Etiology of Peyronie's Disease: Pathogenesis and Genetic Contributions. Sex Med Rev 2020;8:314-323.
Copyright © 2019 International Society for Sexual Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Dupuytren's Disease; Ledderhose Disease; Molecular Genetics; Peyronie’s Disease; Transforming Growth

Year:  2019        PMID: 31540807     DOI: 10.1016/j.sxmr.2019.06.004

Source DB:  PubMed          Journal:  Sex Med Rev        ISSN: 2050-0521


  5 in total

Review 1.  Conservative Therapy for Peyronie's Disease: a Contemporary Review of the Literature.

Authors:  Ayad Yousif; Caleb Natale; Wayne J G Hellstrom
Journal:  Curr Urol Rep       Date:  2021-01-08       Impact factor: 3.092

2.  Are finasteride-related penile curvature/Peyronie's disease Adverse Event Reports worthy of further clinical investigation? Disproportionality analysis based on both the Food and Drug Administration (FDA) and the European Medicines Agency (EMA) pharmacovigilance databases.

Authors:  Nicolò Schifano; Paolo Capogrosso; Luca Boeri; Giuseppe Fallara; Stefania Chiappini; Matthew Rewhorn; Omer Onur Cakir; Hannah Harvey; Fabio Castiglione; Hussain M Alnajjar; Asif Muneer; Federico Deho'; Fabrizio Schifano; Francesco Montorsi; Andrea Salonia
Journal:  Int J Impot Res       Date:  2022-05-05       Impact factor: 2.896

3.  Significant familial clustering of Peyronie's disease in close and distant relatives.

Authors:  Kristina L Allen-Brady; Michael B Christensen; Ashlynn D Sandberg; Alexander W Pastuszak
Journal:  Andrology       Date:  2022-07-13       Impact factor: 4.456

Review 4.  Peyronie's disease - outcomes of collagenase clostridium histolyticum injection: A systematic review.

Authors:  Austin T Mefford; Omer Raheem; Faysal A Yafi; Laith M Alzweri
Journal:  Arab J Urol       Date:  2021-08-16

5.  Intratunical injection of rat-derived bone marrow mesenchymal stem cells prevents fibrosis and is associated with increased Smad7 expression in a rat model of Peyronie's disease.

Authors:  Wenting Wang; Weifang Ding; Xuebao Zhang; Shuang Wu; Tianxi Yu; Xin Cui; Yaqi Xie; Diandong Yang; Chunhua Lin
Journal:  Stem Cell Res Ther       Date:  2022-07-30       Impact factor: 8.079

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.